Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: High Risk
Amphetamin is associated with a high risk profile. Significant physical and psychological risks have been documented. Caution is warranted.
Aggregated from 1 verified experience reports. Community data reflects reported subjective experiences, not clinical outcomes.
The following substances carry an elevated risk of adverse interactions with Amphetamin. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
Route of administration significantly influences the risk profile. Intravenous and inhalation routes carry substantially higher risks than oral administration. Commonly reported routes for Amphetamin:
general
Niedrig starten: orale Dosen von 10–15 mg als Einstieg. Intranasal oder intravenös steigert Euphorie und Abhängigkeitspotenzial erheblich.
general
Nicht nüchtern starten: immer mit Essen konsumieren, regelmäßig trinken (Amphetamin unterdrückt Hunger und Durst).
general
Schlaf priorisieren: Amphetamin-induzierte Schlaflosigkeit akkumuliert zu schwerem Schlafmangel. Crash einplanen.
general
Absolute Kontraindikation: Niemals mit MAO-Hemmern kombinieren — hypertensive Krise, lebensbedrohlich.
general
Häufigkeit begrenzen: Kein täglicher Konsum. Dopamin-System braucht mindestens 3–4 Tage zur Erholung.
general
Bei ersten Zeichen von Paranoia oder Halluzinationen sofort aufhören — das sind Frühzeichen einer Amphetamin-Psychose.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.